Oxidized thymosin .beta.4

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6602519
SERIAL NO

09647117

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the use of oxidized thymosin .beta.4 in therapy, more particularly in the treatment of diseases or conditions associated with an inflammatory response of septic shock.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
IMPERIAL CANCER RESEARCH TECHNOLOGYSARDINIA HOUSE SARDINIA STREET LONDON WC2A 3NL
GLASGOW UNIVERSITY COURT OF THE UNIVERSITY OF THEGILBERT SCOTT BUILDING UNIVERSITY AVENUE GLASGOW G12 8QQ
STEVENSON ROBERT DUNCANARDINING MOOR ROAD STRATHBLANE G63 9EX

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lawrence, Anthony John Glasgow, GB 3 10
Pappin, Darryl John Cecil Herts, GB 3 10
Stevenson, Robert Duncan Ardinning, Moor Road, Strathblane G63 9EX, GB 3 10
Young, John Larkhall, GB 91 1453

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation